Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityMinority InterestNon-Current AssetsOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Lisata Therapeutics (LSTA) Minority Interest (2016 - 2025)

Lisata Therapeutics' Minority Interest history spans 13 years, with the latest figure at -$254000.0 for Q4 2025.

  • For Q4 2025, Minority Interest changed 0.0% year-over-year to -$254000.0; the TTM value through Dec 2025 reached -$254000.0, changed 0.0%, while the annual FY2025 figure was -$254000.0, 0.0% changed from the prior year.
  • Minority Interest reached -$254000.0 in Q4 2025 per LSTA's latest filing, roughly flat from -$254000.0 in the prior quarter.
  • In the past five years, Minority Interest ranged from a high of -$254000.0 in Q1 2023 to a low of -$254000.0 in Q1 2023.
  • Average Minority Interest over 3 years is -$254000.0, with a median of -$254000.0 recorded in 2023.
  • The largest YoY upside for Minority Interest was 0.0% in 2024 against a maximum downside of 0.0% in 2024.
  • A 3-year view of Minority Interest shows it stood at -$254000.0 in 2023, then changed by 0.0% to -$254000.0 in 2024, then changed by 0.0% to -$254000.0 in 2025.
  • Per Business Quant, the three most recent readings for LSTA's Minority Interest are -$254000.0 (Q4 2025), -$254000.0 (Q3 2025), and -$254000.0 (Q2 2025).